Tiziana Life Sciences is trading at $1.03 (-5.50%) amid broader market pressure; no company-specific announcement explaining the decline was identified.
- Reuters reported hotter-than-expected September inflation pushed Treasury yields higher and weighed on U.S. stocks as markets reassessed the likelihood of near-term Fed rate hikes.
- Biotech declined 2.01%, offering broader context but not establishing a direct company-specific catalyst.